{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:01:36Z","timestamp":1779321696342,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2009,1,23]],"date-time":"2009-01-23T00:00:00Z","timestamp":1232668800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1007\/s00277-009-0698-6","type":"journal-article","created":{"date-parts":[[2009,1,22]],"date-time":"2009-01-22T16:11:18Z","timestamp":1232640678000},"page":"897-905","source":"Crossref","is-referenced-by-count":30,"title":["Quantification of free total plasma DNA and minimal residual disease detection in the plasma of children with acute lymphoblastic leukemia"],"prefix":"10.1007","volume":"88","author":[{"given":"Arne Kristian","family":"Schwarz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Stanulla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunnar","family":"Cario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Flohr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosemary","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"M\u00f6ricke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Anker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurice","family":"Stroun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Welte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus R.","family":"Bartram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Schrappe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Schrauder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,1,23]]},"reference":[{"key":"698_CR1","first-page":"646","volume":"37","author":"SA Leon","year":"1977","unstructured":"Leon SA, Shapiro B, Sklaroff DM, Yaros MJ (1977) Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 37:646\u2013650","journal-title":"Cancer Res"},{"key":"698_CR2","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1002\/1097-0142(19830601)51:11<2116::AID-CNCR2820511127>3.0.CO;2-S","volume":"51","author":"B Shapiro","year":"1983","unstructured":"Shapiro B, Chakrabarty M, Cohn EM, Leon SA (1983) Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease. Cancer 51:2116\u20132120 doi: 10.1002\/1097-0142(19830601)51:11<2116::AID-CNCR2820511127>3.0.CO;2-S","journal-title":"Cancer"},{"key":"698_CR3","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0277-5379(87)90266-5","volume":"23","author":"M Stroun","year":"1987","unstructured":"Stroun M, Anker P, Lyautey J, Lederrey C, Maurice PA (1987) Isolation and characterization of DNA from the plasma of cancer patients. Eur J Cancer Clin Oncol 23:707\u2013712 doi: 10.1016\/0277-5379(87)90266-5","journal-title":"Eur J Cancer Clin Oncol"},{"key":"698_CR4","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/sj.leu.2402016","volume":"15","author":"P Anker","year":"2001","unstructured":"Anker P, Stroun M (2001) Tumor-related alterations in circulating DNA, potential for diagnosis, prognosis and detection of minimal residual disease. Leukemia 15:289\u2013291 doi: 10.1038\/sj.leu.2402016","journal-title":"Leukemia"},{"key":"698_CR5","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S0016-5085(97)70121-5","volume":"112","author":"P Anker","year":"1997","unstructured":"Anker P, Lefort F, Vasioukhin V, Lyautey J, Lederrey C, Chen XQ, Stroun M, Mulcahy HE, Farthing MJ (1997) K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer. Gastroenterology 112:1114\u20131120 doi: 10.1016\/S0016-5085(97)70121-5","journal-title":"Gastroenterology"},{"key":"698_CR6","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/nm0996-1033","volume":"2","author":"XQ Chen","year":"1996","unstructured":"Chen XQ, Stroun M, Magnenat JL, Nicod LP, Kurt AM, Lyautey J, Lederrey C, Anker P (1996) Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat Med 2:1033\u20131035 see comments doi: 10.1038\/nm0996-1033","journal-title":"Nat Med"},{"key":"698_CR7","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/nm0996-1035","volume":"2","author":"H Nawroz","year":"1996","unstructured":"Nawroz H, Koch W, Anker P, Stroun M, Sidransky D (1996) Microsatellite alterations in serum DNA of head and neck cancer patients. Nat Med 2:1035\u20131037 doi: 10.1038\/nm0996-1035","journal-title":"Nat Med"},{"key":"698_CR8","first-page":"4728","volume":"58","author":"C Goessl","year":"1998","unstructured":"Goessl C, Heicappell R, Munker R, Anker P, Stroun M, Krause H, Muller M, Miller K (1998) Microsatellite analysis of plasma DNA from patients with clear cell renal carcinoma. Cancer Res 58:4728\u20134732","journal-title":"Cancer Res"},{"key":"698_CR9","first-page":"1567","volume":"59","author":"Y Fujiwara","year":"1999","unstructured":"Fujiwara Y, Chi DD, Wang H, Keleman P, Morton DL, Turner R, Hoon DS (1999) Plasma DNA microsatellites as tumor-specific markers and indicators of tumor progression in melanoma patients. Cancer Res 59:1567\u20131571","journal-title":"Cancer Res"},{"key":"698_CR10","first-page":"67","volume":"59","author":"M Esteller","year":"1999","unstructured":"Esteller M, Sanchez-Cespedes M, Rosell R, Sidransky D, Baylin SB, Herman JG (1999) Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res 59:67\u201370","journal-title":"Cancer Res"},{"key":"698_CR11","first-page":"71","volume":"59","author":"IH Wong","year":"1999","unstructured":"Wong IH, Lo YM, Zhang J, Liew CT, Ng MH, Wong N, Lai PB, Lau WY, Hjelm NM, Johnson PJ (1999) Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Cancer Res 59:71\u201373","journal-title":"Cancer Res"},{"key":"698_CR12","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/sj.bjc.6690495","volume":"80","author":"JM Silva","year":"1999","unstructured":"Silva JM, Dominguez G, Villanueva MJ, Gonzalez R, Garcia JM, Corbacho C, Provencio M, Espana P, Bonilla F (1999) Aberrant DNA methylation of the p16INK4a gene in plasma DNA of breast cancer patients. Br J Cancer 80:1262\u20131264 doi: 10.1038\/sj.bjc.6690495","journal-title":"Br J Cancer"},{"key":"698_CR13","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1365-2141.1994.tb04828.x","volume":"86","author":"V Vasioukhin","year":"1994","unstructured":"Vasioukhin V, Anker P, Maurice P, Lyautey J, Lederrey C, Stroun M (1994) Point mutations of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia. Br J Haematol 86:774\u2013779 doi: 10.1111\/j.1365-2141.1994.tb04828.x","journal-title":"Br J Haematol"},{"key":"698_CR14","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1182\/blood.V90.12.4953","volume":"90","author":"N Frickhofen","year":"1997","unstructured":"Frickhofen N, Muller E, Sandherr M, Binder T, Bangerter M, Wiest C, Enz M, Heimpel H (1997) Rearranged Ig heavy chain DNA is detectable in cell-free blood samples of patients with B-cell neoplasia. Blood 90:4953\u20134960","journal-title":"Blood"},{"key":"698_CR15","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1182\/blood-2003-06-1840","volume":"103","author":"A Rogers","year":"2004","unstructured":"Rogers A, Joe Y, Manshouri T, Dey A, Jilani I, Giles F, Estey E, Freireich E, Keating M, Kantarjian H, Albitar M (2004) Relative increase in leukemia-specific DNA in peripheral blood plasma from patients with acute myeloid leukemia and myelodysplasia. Blood 103:2799\u20132801 doi: 10.1182\/blood-2003-06-1840","journal-title":"Blood"},{"key":"698_CR16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.seminhematol.2008.09.007","volume":"46","author":"M Stanulla","year":"2009","unstructured":"Stanulla M, Schrappe M (2009) Treatment of childhood acute lymphoblastic leukemia. Semin Hematol 46:52\u201363 doi: 10.1053\/j.seminhematol.2008.09.007","journal-title":"Semin Hematol"},{"key":"698_CR17","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1182\/blood-2004-04-1552","volume":"105","author":"G Cario","year":"2005","unstructured":"Cario G, Stanulla M, Fine BM, Teuffel O, Neuhoff NV, Schrauder A, Flohr T, Schafer BW, Bartram CR, Welte K, Schlegelberger B, Schrappe M (2005) Distinct gene expression profiles determine molecular treatment response in childhood acute lymphoblastic leukemia. Blood 105:821\u2013826 doi: 10.1182\/blood-2004-04-1552","journal-title":"Blood"},{"key":"698_CR18","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJM199808273390904","volume":"339","author":"H Cave","year":"1998","unstructured":"Cave H, van der Werff ten Bosch J, Suciu S, Guidal C, Waterkeyn C, Otten J, Bakkus M, Thielemans K, Grandchamp B, Vilmer E (1998) Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer\u2014Childhood Leukemia Cooperative Group. N Engl J Med 339:591\u2013598 see comments doi: 10.1056\/NEJM199808273390904","journal-title":"N Engl J Med"},{"key":"698_CR19","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/S0140-6736(98)04058-6","volume":"352","author":"JJM Dongen van","year":"1998","unstructured":"van Dongen JJM, Seriu T, Panzer-Grumayer ER, Biondi A, Pongers-Willemse MJ, Corral L, Stolz F, Schrappe M, Masera G, Kamps WA, Gadner H, van Wering ER, Ludwig W-D, Basso G, de Bruijn MAC, Cazzaniga G, Hettinger K, van der Does-van den Berg A, Hop WCJ, Riehm H, Bartram CR (1998) Prognostic value of minimal residual disease in childhood acute lymphoblastic leukemia: a prospective study of the International BFM Study Group. Lancet 352:1731\u20131738 doi: 10.1016\/S0140-6736(98)04058-6","journal-title":"Lancet"},{"key":"698_CR20","first-page":"31","volume":"31","author":"T Flohr","year":"2008","unstructured":"Flohr T, Schrauder A, Cazzaniga G, Panzer-Grumayer R, van der Velden V, Fischer S, Stanulla M, Basso G, Niggli FK, Schafer BW, Sutton R, Koehler R, Zimmermann M, Valsecchi MG, Gadner H, Masera G, Schrappe M, van Dongen JJ, Biondi A, Bartram CR (2008) Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia. Leukemia 31:31","journal-title":"Leukemia"},{"key":"698_CR21","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1046\/j.1537-2995.2001.41020276.x","volume":"41","author":"TH Lee","year":"2001","unstructured":"Lee TH, Montalvo L, Chrebtow V, Busch MP (2001) Quantitation of genomic DNA in plasma and serum samples: higher concentrations of genomic DNA found in serum than in plasma. Transfusion 41:276\u2013282 doi: 10.1046\/j.1537-2995.2001.41020276.x","journal-title":"Transfusion"},{"key":"698_CR22","first-page":"2375","volume":"35","author":"P Anker","year":"1975","unstructured":"Anker P, Stroun M, Maurice PA (1975) Spontaneous release of DNA by human blood lymphoctyes as shown in an in vitro system. Cancer Res 35:2375\u20132382","journal-title":"Cancer Res"},{"key":"698_CR23","first-page":"3281","volume":"60","author":"M Nakao","year":"2000","unstructured":"Nakao M, Janssen JW, Flohr T, Bartram CR (2000) Rapid and reliable quantification of minimal residual disease in acute lymphoblastic leukemia using rearranged immunoglobulin and T-cell receptor loci by LightCycler technology. Cancer Res 60:3281\u20133289","journal-title":"Cancer Res"},{"key":"698_CR24","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/sj.leu.2402922","volume":"17","author":"VH Velden van der","year":"2003","unstructured":"van der Velden VH, Hochhaus A, Cazzaniga G, Szczepanski T, Gabert J, van Dongen JJ (2003) Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects. Leukemia 17:1013\u20131034 doi: 10.1038\/sj.leu.2402922","journal-title":"Leukemia"},{"key":"698_CR25","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/sj.leu.2404586","volume":"21","author":"VH Velden van der","year":"2007","unstructured":"van der Velden VH, Cazzaniga G, Schrauder A, Hancock J, Bader P, Panzer-Grumayer ER, Flohr T, Sutton R, Cave H, Madsen HO, Cayuela JM, Trka J, Eckert C, Foroni L, Zur Stadt U, Beldjord K, Raff T, van der Schoot CE, van Dongen JJ (2007) Analysis of minimal residual disease by Ig\/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data. Leukemia 21:604\u2013611","journal-title":"Leukemia"},{"key":"698_CR26","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/sj.leu.2404535","volume":"21","author":"VH Velden van der","year":"2007","unstructured":"van der Velden VH, Panzer-Grumayer ER, Cazzaniga G, Flohr T, Sutton R, Schrauder A, Basso G, Schrappe M, Wijkhuijs JM, Konrad M, Bartram CR, Masera G, Biondi A, van Dongen JJ (2007) Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting. Leukemia 21:706\u2013713","journal-title":"Leukemia"},{"key":"698_CR27","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1749-6632.2000.tb06608.x","volume":"906","author":"M Stroun","year":"2000","unstructured":"Stroun M, Maurice P, Vasioukhin V, Lyautey J, Lederrey C, Lefort F, Rossier A, Chen XQ, Anker P (2000) The origin and mechanism of circulating DNA. Ann N Y Acad Sci 906:161\u2013168","journal-title":"Ann N Y Acad Sci"},{"key":"698_CR28","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1159\/000226740","volume":"46","author":"M Stroun","year":"1989","unstructured":"Stroun M, Anker P, Maurice P, Lyautey J, Lederrey C, Beljanski M (1989) Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology 46:318\u2013322","journal-title":"Oncology"},{"key":"698_CR29","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0304-3835(95)03742-F","volume":"91","author":"GJ Fournie","year":"1995","unstructured":"Fournie GJ, Courtin JP, Laval F, Chale JJ, Pourrat JP, Pujazon MC, Lauque D, Carles P (1995) Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours. Cancer Lett 91:221\u2013227 doi: 10.1016\/0304-3835(95)03742-F","journal-title":"Cancer Lett"},{"key":"698_CR30","first-page":"1659","volume":"61","author":"S Jahr","year":"2001","unstructured":"Jahr S, Hentze H, Englisch S, Hardt D, Fackelmayer FO, Hesch RD, Knippers R (2001) DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 61:1659\u20131665","journal-title":"Cancer Res"},{"key":"698_CR31","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/jcla.10081","volume":"17","author":"CN Li","year":"2003","unstructured":"Li CN, Hsu HL, Wu TL, Tsao KC, Sun CF, Wu JT (2003) Cell-free DNA is released from tumor cells upon cell death: a study of tissue cultures of tumor cell lines. J Clin Lab Anal 17:103\u2013107 doi: 10.1002\/jcla.10081","journal-title":"J Clin Lab Anal"},{"key":"698_CR32","first-page":"753","volume":"37","author":"D Jachertz","year":"1979","unstructured":"Jachertz D, Anker P, Maurice PA, Stroun M (1979) Information carried by the DNA released by antigen-stimulated lymphocytes. Immunology 37:753\u2013763","journal-title":"Immunology"},{"key":"698_CR33","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1749-6632.2001.tb03894.x","volume":"945","author":"M Stroun","year":"2001","unstructured":"Stroun M, Lyautey J, Lederrey C, Mulcahy HE, Anker P (2001) Alu repeat sequences are present in increased proportions compared to a unique gene in plasma\/serum DNA: evidence for a preferential release from viable cells? Ann N Y Acad Sci 945:258\u2013264","journal-title":"Ann N Y Acad Sci"},{"key":"698_CR34","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1182\/blood-2002-04-1130","volume":"100","author":"E Coustan-Smith","year":"2002","unstructured":"Coustan-Smith E, Sancho J, Hancock ML, Razzouk BI, Ribeiro RC, Rivera GK, Rubnitz JE, Sandlund JT, Pui CH, Campana D (2002) Use of peripheral blood instead of bone marrow to monitor residual disease in children with acute lymphoblastic leukemia. Blood 100:2399\u20132402 doi: 10.1182\/blood-2002-04-1130","journal-title":"Blood"},{"key":"698_CR35","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/sj.leu.2402636","volume":"16","author":"VH Velden van der","year":"2002","unstructured":"van der Velden VH, Jacobs DC, Wijkhuijs AJ, Comans-Bitter WM, Willemse MJ, Hahlen K, Kamps WA, van Wering ER, van Dongen JJ (2002) Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL. Leukemia 16:1432\u20131436 doi: 10.1038\/sj.leu.2402636","journal-title":"Leukemia"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-009-0698-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-009-0698-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-009-0698-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T23:57:16Z","timestamp":1589500636000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-009-0698-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,23]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["698"],"URL":"https:\/\/doi.org\/10.1007\/s00277-009-0698-6","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,23]]}}}